Long-acting injectable versus oral antipsychotics for schizophrenia - Authors' reply
- PMID: 34147177
- DOI: 10.1016/S2215-0366(21)00203-0
Long-acting injectable versus oral antipsychotics for schizophrenia - Authors' reply
Conflict of interest statement
TK reports personal fees from Banyu, Eli Lilly, Janssen, Kyowa Pharmaceutical Industry, Lundbeck, Novartis, Otsuka, Sumitomo Dainippon Pharma, and Takeda, and grants from Sumitomo Dainippon Pharma and Otsuka, outside the submitted work. KH is an employee of Sumitomo Dainippon Pharma. SK reports personal fees from Sumitomo Dainippon Pharma , Meiji Seika Pharma, and Mochida Pharmaceutical, outside the submitted work. JMK reports personal fees from Alkermes, Acadia, Sumitomo Dainippon Pharma, Intra-Cellular Therapies, Merck, Neurocrine, Reviva, Roche, Saladex, Sunovion, Takeda, Teva, and LB Pharma, and grants and personal fees from H Lundbeck, Janssen, and Otsuka, outside the submitted work. JMK is also a shareholder of LB Pharma and The Vanguard Research Group. CUC reports personal fees from Acadia, Alkermes, Allergan, Angelini, Axsome, Bristol Myers Squibb, Gedeon Richter, Intra-Cellular Therapies, Janssen, Karuna, LB Pharma, Lundbeck, MedAvante-ProPhase, MedinCell, Medscape, Merck, Mitsubishi Tanabe Pharma, Mylan, Neurocrine, Noven, Otsuka, Pfizer, Recordati, Rovi, Servier, Sumitomo Dainippon Pharma, Sunovion, Supernus, Takeda, and Teva, and royalties from UpToDate, outside the submitted work. CUC is also a stock option holder of LB Pharma. TK and KH contributed equally to this Comment.
Comment on
-
Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies.Lancet Psychiatry. 2021 May;8(5):387-404. doi: 10.1016/S2215-0366(21)00039-0. Epub 2021 Apr 13. Lancet Psychiatry. 2021. PMID: 33862018
-
Long-acting injectable versus oral antipsychotics for schizophrenia.Lancet Psychiatry. 2021 Jul;8(7):566-567. doi: 10.1016/S2215-0366(21)00200-5. Lancet Psychiatry. 2021. PMID: 34147176 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical